调研-话题@MedSci

#调研#

95篇内容 | 2597人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2205878, encodeId=39b522058e859, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=医路相伴，礼赞心选|最受欢迎礼品有奖调研！, objectType=article, longId=826872, objectId=cfcb8268e23e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240521/1716282540617_8538692.png, objectUrl=/article/show_article.do?id=cfcb8268e23e, replyNumber=0, likeNumber=100, createdTime=2024-05-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cfcb8268e23e, moduleTitle=医路相伴，礼赞心选|最受欢迎礼品有奖调研！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfcb8268e23e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1751513, encodeId=dd091e5151389, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=高血压全称防治调研问卷-贡献您的专业意见, objectType=article, longId=733038, objectId=b627e33038dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b627e33038dc, replyNumber=0, likeNumber=65, createdTime=2023-06-23, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b627e33038dc, moduleTitle=高血压全称防治调研问卷-贡献您的专业意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b627e33038dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751508, encodeId=43301e51508ec, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=世界高血压日，邀您参加高血压院外管理有偿调研, objectType=article, longId=727401, objectId=c802e27401cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c802e27401cf, replyNumber=0, likeNumber=103, createdTime=2022-09-09, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c802e27401cf, moduleTitle=世界高血压日，邀您参加高血压院外管理有偿调研, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c802e27401cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751511, encodeId=d2541e51511b8, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=肝硬化腹水及相关并发症中人血白蛋白应用调研-同肝道白上海启动会, objectType=article, longId=728013, objectId=0d21e2801350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d21e2801350, replyNumber=0, likeNumber=108, createdTime=2023-01-19, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d21e2801350, moduleTitle=肝硬化腹水及相关并发症中人血白蛋白应用调研-同肝道白上海启动会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d21e2801350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751510, encodeId=5cac1e5151052, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=JAMA Netw open：全球调研——低收入和中等收入国家5岁以下儿童全因死亡率的年龄分布, objectType=article, longId=727835, objectId=90fde27835e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90fde27835e8, replyNumber=0, likeNumber=83, createdTime=2023-02-27, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90fde27835e8, moduleTitle=JAMA Netw open：全球调研——低收入和中等收入国家5岁以下儿童全因死亡率的年龄分布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90fde27835e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751507, encodeId=a68f1e51507b7, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=【有奖调研】国自然申请调查问卷活动！, objectType=article, longId=725485, objectId=5189e2548517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5189e2548517, replyNumber=0, likeNumber=122, createdTime=2022-05-03, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5189e2548517, moduleTitle=【有奖调研】国自然申请调查问卷活动！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5189e2548517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751509, encodeId=c9f81e51509d3, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=【40元京豆梅斯有奖问卷】高血压患者院外管理的现状有偿调研, objectType=article, longId=727434, objectId=7925e27434cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7925e27434cf, replyNumber=0, likeNumber=91, createdTime=2023-04-11, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7925e27434cf, moduleTitle=【40元京豆梅斯有奖问卷】高血压患者院外管理的现状有偿调研, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7925e27434cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751512, encodeId=0f5d1e515121c, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=看直播参与调研-SAGE周边限时领取, objectType=article, longId=730351, objectId=e1d4e3035182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1d4e3035182, replyNumber=0, likeNumber=123, createdTime=2023-02-19, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1d4e3035182, moduleTitle=看直播参与调研-SAGE周边限时领取, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1d4e3035182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751514, encodeId=e0181e5151451, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=【30秒小调研】抽U盘，桌垫，积分参与就送，100%有奖, objectType=article, longId=735924, objectId=8e16e359249c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e16e359249c, replyNumber=0, likeNumber=108, createdTime=2022-08-21, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e16e359249c, moduleTitle=【30秒小调研】抽U盘，桌垫，积分参与就送，100%有奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e16e359249c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751506, encodeId=4e391e51506a1, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=《全国基因测序服务质量现状调研》诚邀您参加！, objectType=article, longId=302127, objectId=e97530212e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e97530212e5a, replyNumber=0, likeNumber=89, createdTime=2022-11-22, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e97530212e5a, moduleTitle=《全国基因测序服务质量现状调研》诚邀您参加！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e97530212e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751505, encodeId=10fb1e5150555, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=晚期肝癌（HCC）诊疗现状调研, objectType=article, longId=301841, objectId=af21301841f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af21301841f8, replyNumber=0, likeNumber=112, createdTime=2022-07-13, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af21301841f8, moduleTitle=晚期肝癌（HCC）诊疗现状调研, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af21301841f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751503, encodeId=1dc61e515034a, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=调研：对于欧盟和英美准备在2月1日全面解封，变相宣告疫情结束，你支持么？, objectType=article, longId=294945, objectId=3e6229494590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e6229494590, replyNumber=0, likeNumber=124, createdTime=2022-07-29, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e6229494590, moduleTitle=调研：对于欧盟和英美准备在2月1日全面解封，变相宣告疫情结束，你支持么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e6229494590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751504, encodeId=86eb1e515040c, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=医调研2.0升级上线, objectType=article, longId=724703, objectId=8a2ae2470317, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a2ae2470317, replyNumber=0, likeNumber=65, createdTime=2022-11-10, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a2ae2470317, moduleTitle=医调研2.0升级上线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a2ae2470317)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751502, encodeId=e8651e515027a, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=精鼎医药在WCG CenterWatch全球研究中心关系调研中被评为 "值得合作的CRO", objectType=article, longId=294185, objectId=e70429418531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e70429418531, replyNumber=0, likeNumber=79, createdTime=2022-11-27, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e70429418531, moduleTitle=精鼎医药在WCG CenterWatch全球研究中心关系调研中被评为 "值得合作的CRO", moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e70429418531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751501, encodeId=cb431e5150168, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=调研结果|关于医疗美容术后产品使用接受度, objectType=article, longId=214646, objectId=5ef521464632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ef521464632, replyNumber=0, likeNumber=70, createdTime=2022-01-12, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ef521464632, moduleTitle=调研结果|关于医疗美容术后产品使用接受度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ef521464632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751496, encodeId=61881e51496d6, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=医护人员年收入水平的小调研（2020-2021）, objectType=article, longId=203749, objectId=6987203e4969, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6987203e4969, replyNumber=0, likeNumber=103, createdTime=2021-10-12, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6987203e4969, moduleTitle=医护人员年收入水平的小调研（2020-2021）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6987203e4969)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751497, encodeId=e6421e5149757, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=青少年健康校园行调研, objectType=article, longId=204562, objectId=ee9220456262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee9220456262, replyNumber=0, likeNumber=122, createdTime=2021-02-13, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee9220456262, moduleTitle=青少年健康校园行调研, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee9220456262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751499, encodeId=b4361e514996e, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=浙江有关遗传性血管性水肿调研出炉聚焦罕见病患者困境, objectType=article, longId=208022, objectId=3b102080221a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b102080221a, replyNumber=0, likeNumber=85, createdTime=2022-02-09, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b102080221a, moduleTitle=浙江有关遗传性血管性水肿调研出炉聚焦罕见病患者困境, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b102080221a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751498, encodeId=57381e514981d, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=重磅！Nature调研：近九成科学家认为新冠病毒将长期与人类共存, objectType=article, longId=207365, objectId=5b5b20e365b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b5b20e365b3, replyNumber=0, likeNumber=60, createdTime=2021-03-02, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b5b20e365b3, moduleTitle=重磅！Nature调研：近九成科学家认为新冠病毒将长期与人类共存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b5b20e365b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1751493, encodeId=d8271e5149335, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, objectTitle=刚刚！国家卫健委发布2020家医宣传通知，调研基层医务人员待遇, objectType=article, longId=194103, objectId=6d4b1941034f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d4b1941034f, replyNumber=0, likeNumber=128, createdTime=2020-11-07, rootId=0, userName=天堂的云, userId=958d36313994, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d4b1941034f, moduleTitle=刚刚！国家卫健委发布2020家医宣传通知，调研基层医务人员待遇, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d4b1941034f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

调研

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#调研#

医路相伴，礼赞心选|最受欢迎礼品有奖调研！

2024-05-21发表于上海

天堂的云 (审核中...)

前往app查看评论内容

#调研#

高血压全称防治调研问卷-贡献您的专业意见

2023-06-23

天堂的云 (审核中...)

前往app查看评论内容

#调研#

世界高血压日，邀您参加高血压院外管理有偿调研

2022-09-09

天堂的云 (审核中...)

前往app查看评论内容

#调研#

肝硬化腹水及相关并发症中人血白蛋白应用调研-同肝道白上海启动会

2023-01-19

天堂的云 (审核中...)

前往app查看评论内容

#调研#

JAMA Netw open：全球调研——低收入和中等收入国家5岁以下儿童全因死亡率的年龄分布

2023-02-27

天堂的云 (审核中...)

前往app查看评论内容

#调研#

【有奖调研】国自然申请调查问卷活动！

2022-05-03

天堂的云 (审核中...)

前往app查看评论内容

#调研#

【40元京豆梅斯有奖问卷】高血压患者院外管理的现状有偿调研

2023-04-11

天堂的云 (审核中...)

前往app查看评论内容

#调研#

看直播参与调研-SAGE周边限时领取

2023-02-19

天堂的云 (审核中...)

前往app查看评论内容

#调研#

【30秒小调研】抽U盘，桌垫，积分参与就送，100%有奖

2022-08-21

天堂的云 (审核中...)

前往app查看评论内容

#调研#

《全国基因测序服务质量现状调研》诚邀您参加！

2022-11-22

天堂的云 (审核中...)

前往app查看评论内容

#调研#

晚期肝癌（HCC）诊疗现状调研

2022-07-13

天堂的云 (审核中...)

前往app查看评论内容

#调研#

调研：对于欧盟和英美准备在2月1日全面解封，变相宣告疫情结束，你支持么？

2022-07-29

天堂的云 (审核中...)

前往app查看评论内容

#调研#

医调研2.0升级上线

2022-11-10

天堂的云 (审核中...)

前往app查看评论内容

#调研#

精鼎医药在WCG CenterWatch全球研究中心关系调研中被评为 "值得合作的CRO"

2022-11-27

天堂的云 (审核中...)

前往app查看评论内容

#调研#

调研结果|关于医疗美容术后产品使用接受度

2022-01-12

天堂的云 (审核中...)

前往app查看评论内容

#调研#

医护人员年收入水平的小调研（2020-2021）

2021-10-12

天堂的云 (审核中...)

前往app查看评论内容

#调研#

青少年健康校园行调研

2021-02-13

天堂的云 (审核中...)

前往app查看评论内容

#调研#

浙江有关遗传性血管性水肿调研出炉聚焦罕见病患者困境

2022-02-09

天堂的云 (审核中...)

前往app查看评论内容

#调研#

重磅！Nature调研：近九成科学家认为新冠病毒将长期与人类共存

2021-03-02

天堂的云 (审核中...)

前往app查看评论内容

#调研#

刚刚！国家卫健委发布2020家医宣传通知，调研基层医务人员待遇

2020-11-07

科室
- - 订阅+
  - 更多科室
工具
服务